Document Report Card

Basic Information

ID: ALA4196115

Journal: ACS Med Chem Lett

Title: MK-7622: A First-in-Class M1 Positive Allosteric Modulator Development Candidate.

Authors: Beshore DC, N Di Marco C, Chang RK, Greshock TJ, Ma L, Wittmann M, Seager MA, Koeplinger KA, Thompson CD, Fuerst J, Hartman GD, Bilodeau MT, Ray WJ, Kuduk SD.

Abstract: Identification of ligands that selectively activate the M1 muscarinic signaling pathway has been sought for decades to treat a range of neurological and cognitive disorders. Herein, we describe the optimization efforts focused on addressing key physicochemical and safety properties, ultimately leading to the clinical candidate MK-7622, a highly selective positive allosteric modulator of the M1 muscarinic receptor that has entered Phase II studies in patients with Alzheimer's disease.

CiteXplore: 30034595

DOI: 10.1021/acsmedchemlett.8b00095